Headache management
"headache" AND "management"
90% of patients presenting to primary care with headache have migraine. - Harrison's Principles of Internal Medicine 22E, 2025
| Drug | Route | Dose |
|---|---|---|
| Sumatriptan | PO | 50-100 mg |
| Rizatriptan | PO | 10 mg |
| Eletriptan | PO | 40 mg |
| Almotriptan | PO | 12.5 mg |
| Zolmitriptan | PO/nasal | 2.5 mg / 5 mg nasal |
| Sumatriptan | SC | 6 mg (fastest onset) |
| Sumatriptan | Nasal | 20 mg |
| Rimegepant (CGRP antagonist) | PO | 75 mg |
| Ubrogepant (CGRP antagonist) | PO | 50-100 mg |
| Lasmiditan (5-HT1F agonist) | PO | 50-200 mg |
| Situation | Preferred Option |
|---|---|
| Early vomiting | Zolmitriptan 5 mg nasal / Sumatriptan 6 mg SC |
| Rapid onset headache | SC or nasal triptans / DHE IM |
| Headache recurrence | Ergotamine 2 mg PR / Naratriptan 2.5 mg / Eletriptan 40 mg |
| Poor tolerance of acute therapy | Naratriptan, Almotriptan, Rimegepant, neuromodulation |
| Menstrual migraine prevention | Frovatriptan, Rimegepant, or estrogen patches during menses |
| Drug Class | Agents | Notes |
|---|---|---|
| Beta-blockers | Propranolol, metoprolol, timolol | First-line; avoid in asthma, depression |
| Anticonvulsants | Topiramate, valproate | FDA-approved; valproate teratogenic |
| TCAs | Amitriptyline | Also treats comorbid depression/sleep |
| Calcium channel blockers | Verapamil | More evidence for cluster headache |
| CGRP monoclonal antibodies | Erenumab, fremanezumab, galcanezumab, eptinezumab | New class; SC/IV monthly; very effective |
| CGRP receptor antagonists | Rimegepant (also used acutely) | Oral, twice-weekly for prevention |
| Supplements | Magnesium, riboflavin (B2), CoQ10, feverfew | Modest evidence, good safety |
| Feature | Cluster | Paroxysmal Hemicrania | SUNCT/SUNA |
|---|---|---|---|
| Duration | 15-180 min | 2-30 min | 5-240 sec |
| Frequency | 1-8/day | 1-20/day | 3-200/day |
| Abortive Rx | O2, sumatriptan SC | Indomethacin (diagnostic) | IV lidocaine |
| Prevention | Verapamil, galcanezumab | Indomethacin | Lamotrigine |
Abdominal koch’s pain abdomen mana
"abdominal tuberculosis" AND management
| Form | Features |
|---|---|
| Intestinal TB | Terminal ileum/ileocaecal region most common (75%), ulcerative/hypertrophic/ulcerohypertrophic |
| Tuberculous peritonitis | Wet ascitic type (90%), dry fibrotic type (rare) |
| Mesenteric lymphadenitis | Enlarged nodes, central caseation - can be seen on CT |
| Solid organ | Liver, spleen involvement less common |
These patients are often extremely ill - dehydrated, malnourished, anaemic, often with active pulmonary TB. - Bailey & Love

| Phase | Duration | Drugs | Abbreviation |
|---|---|---|---|
| Intensive phase | 2 months | Isoniazid (H) + Rifampicin (R) + Pyrazinamide (Z) + Ethambutol (E) | 2HRZE |
| Continuation phase | 4 months | Isoniazid (H) + Rifampicin (R) | 4HR |
| Total | 6 months |
For extrapulmonary TB including abdominal TB, a total duration of 12-18 months may be preferred in some guidelines/settings due to the depth of tissue penetration and risk of relapse. - Bailey & Love
| Indication | Notes |
|---|---|
| Intestinal obstruction not responding to medical therapy | Most common surgical indication |
| Intestinal perforation | Emergency - peritoneal contamination |
| Intestinal hemorrhage | Uncontrolled bleeding |
| Abdominal abscess | Drainage required |
| Diagnostic uncertainty | Biopsy when endoscopic diagnosis not possible |
| Fistula formation | Entero-enteric or entero-cutaneous |
Key principle: Many cases of intestinal obstruction from TB will respond to anti-TB treatment without surgery. Always give adequate medical therapy before deciding on surgical intervention. - Bailey & Love, Summary Box 65.6
| Surgical Procedure | Indication |
|---|---|
| Limited ileocolic resection + anastomosis | Terminal ileal/ileocolic hyperplastic disease |
| Strictureplasty | Single ileal stricture (bowel-conserving) |
| Bowel resection | Multiple closely placed strictures |
| Right hemicolectomy | Extensive ileocolic disease precluding limited resection |
Surgical principles are similar to Crohn's disease - resections should be kept as conservative as possible to prevent short bowel syndrome. - Bailey & Love, 28th Ed.
| Feature | Intestinal TB | Crohn's Disease |
|---|---|---|
| Ileocaecal valve | Incompetent (both sides involved) | Usually competent |
| Ulcer orientation | Transverse, circumferential | Longitudinal (along bowel axis) |
| Lymph nodes | Large (>1 cm), hypodense (caseous) | Small, non-necrotic |
| Stierlin sign | Present | Absent |
| Granulomas | Caseating | Non-caseating |
| AFB/PCR | Positive | Negative |
Suspected Abdominal Koch's (Pain abdomen)
↓
Red flags? (Obstruction / Perforation / Haemorrhage)
↓ ↓
YES NO
↓ ↓
Emergency resuscitation Confirm diagnosis
+ surgery if required (Colonoscopy + biopsy, CT, ADA)
↓
START ANTI-TB THERAPY
(2HRZE → 4HR, 6-18 months)
↓
Clinical response within 2 weeks?
↓ ↓
YES NO
↓ ↓
Continue ATT Re-evaluate diagnosis
↓ Consider MDR-TB / biopsy
Post-treatment imaging
↓
Residual stricture/obstruction?
↓
ELECTIVE SURGERY
(Strictureplasty / Limited resection)
U/l limb swelling differentials
| Question | Narrows Towards |
|---|---|
| Unilateral or bilateral? | Unilateral = local/structural; Bilateral = systemic |
| Pitting or non-pitting? | Pitting = venous/cardiac/hypoalbuminaemia; Non-pitting = lymphedema/myxoedema |
| Acute or chronic onset? | Acute = DVT, cellulitis, trauma; Chronic = lymphedema, tumour |
| Hot, red, tender? | Infective/inflammatory |
| Associated neck/facial swelling? | SVC syndrome |
| Recent surgery/malignancy? | Lymphedema, DVT, tumour recurrence |
| Trauma/strenuous exercise? | Paget-Schroetter, haematoma, compartment syndrome |
| Cause | Key Features |
|---|---|
| Congestive cardiac failure | Bilateral pitting oedema, JVP raised, dyspnoea |
| Hypoalbuminaemia (nephrotic, cirrhosis, malnutrition) | Bilateral pitting, low albumin |
| Hypothyroidism (myxoedema) | Non-pitting, periorbital puffiness, bradycardia, cold intolerance |
| Renal failure | Bilateral pitting oedema, uraemia |
| Anaphylaxis / Angioedema | Rapid onset, urticaria, laryngeal oedema, hypotension |
| Lipoedema | Bilateral fat deposition (spares hands/feet), not true oedema |
| Drug | Mechanism |
|---|---|
| Calcium channel blockers (amlodipine) | Arteriolar dilatation → dependent oedema |
| NSAIDs | Sodium/water retention |
| Corticosteroids | Fluid retention |
| Tamoxifen | DVT risk (relative risk ~3x) |
| IV contrast / drug reactions | Local/allergic |
| Chemotherapy agents | Venous fibrosis / lymphatic damage |
| Diagnosis | Onset | Laterality | Pitting | Key Feature |
|---|---|---|---|---|
| UE-DVT | Acute | Unilateral | Yes | Risk factors, collateral veins |
| Cellulitis | Acute | Unilateral | Yes | Hot, red, tender, +/- fever |
| Compartment syndrome | Acute | Unilateral | No | Disproportionate pain, tight |
| Lymphedema (post-mastectomy) | Subacute/chronic | Unilateral | No (late) | H/o breast cancer treatment |
| SVC syndrome | Subacute | Bilateral (+ face/neck) | Yes | Collaterals, dyspnoea |
| Paget-Schroetter (DVT) | Acute | Unilateral | Yes | Young athlete, exertion |
| Soft tissue tumour | Chronic | Unilateral | No | Firm, painless mass |
| Angioedema | Minutes | Bilateral or focal | No | Allergic trigger, urticaria |
| Fracture/haematoma | Acute post-trauma | Unilateral | Variable | History of trauma |
Always think about DVT in a patient with unilateral limb swelling. - Symptom to Diagnosis: An Evidence-Based Guide, 4th Ed.
u/l unilateral swelling differentials
| Category | Condition |
|---|---|
| Vascular | UE-DVT, Superficial thrombophlebitis, AV fistula, Venous injury |
| Infective | Cellulitis, Erysipelas, Necrotizing fasciitis, Abscess, Lymphangitis |
| Traumatic | Fracture, Haematoma, Compartment syndrome, Muscle tear, Dislocation |
| Autoimmune / Inflammatory | Gout, Pseudogout, Septic arthritis, CRPS, Rheumatoid flare, DVT-related |
| Metabolic | Hypothyroidism (myxoedema - rare, usually bilateral) |
| Iatrogenic / Drug | IV extravasation, PICC line thrombosis, Drug reaction |
| Neoplastic | Soft tissue sarcoma, Lipoma, Ganglion, Axillary nodal mass, Metastasis |
| Congenital / Lymphatic | Primary lymphedema, Thoracic outlet syndrome (venous) |
UNILATERAL ARM SWELLING
|
┌────┴─────┐
ACUTE CHRONIC
| |
┌─┴──┐ ┌──┴───┐
Hot/red? Pain/trauma? Non-pitting? Post-mastectomy?
| | | |
Cellulitis Fracture Lymphedema BCRL/lymphedema
Erysipelas Haematoma CRPS Stewart-Treves
NF Compartment
syndrome
|
History of catheter/
indwelling device/
malignancy/exertion?
|
DVT
| Diagnosis | Onset | Skin Changes | Pain | Fever | Key Clue |
|---|---|---|---|---|---|
| UE-DVT | Acute | Erythema/cyanosis | Moderate | No | Catheter / athlete / collaterals |
| Cellulitis | Acute | Hot, red, indistinct border | Yes | Often | Entry site, lymphangitis |
| Erysipelas | Acute | Raised, sharp border | Yes | High | Strep, face/limb |
| Necrotizing fasciitis | Acute | Bullae, crepitus, necrosis | Extreme | High, septic | Pain >> appearance |
| Compartment syndrome | Acute | Tense, tight | Extreme (passive stretch) | No | Post-fracture/trauma |
| Lymphedema | Chronic | Non-pitting, skin thickening | No | No | Post-mastectomy, non-pitting |
| Haematoma | Acute post-trauma | Bruising, ecchymosis | Yes | No | Trauma/anticoagulation |
| Gout | Acute | Red, periarticular | Extreme | Sometimes | Joint-centred, urate |
| CRPS | Subacute | Shiny, colour change | Burning | No | Allodynia, post-injury |
| Soft tissue tumour | Chronic | Normal | No | No | Mass, progressive |
| SVT | Acute | Linear erythema | Localised | Low | Palpable cord along vein |
Upper limb unilateral swelling differentials
| Question | Points Towards |
|---|---|
| Acute vs chronic onset? | Acute = DVT, cellulitis, trauma; Chronic = lymphedema, tumour |
| Hot + red + tender? | Infective/inflammatory |
| After trauma/exertion? | Fracture, haematoma, Paget-Schroetter DVT |
| Indwelling catheter/PICC/pacemaker? | Secondary UE-DVT |
| Previous breast cancer treatment? | Post-mastectomy lymphedema |
| Pain disproportionate to appearance? | Compartment syndrome, necrotizing fasciitis |
| Palpable cord along vein? | Superficial thrombophlebitis |
| Joint-centred swelling? | Septic arthritis, gout/pseudogout |
| Firm/painless/progressive mass? | Soft tissue tumour |
| Visible collateral veins on chest/shoulder? | UE-DVT, SVC obstruction |
| Condition | Key Features |
|---|---|
| Upper Extremity DVT (MUST NOT MISS) | Arm pain, swelling, heaviness; dilated collaterals on chest/shoulder; risk: catheter, athlete (Paget-Schroetter), malignancy, thrombophilia; PE risk up to 33% |
| Paget-Schroetter syndrome | Young athlete, dominant arm, strenuous repetitive exertion; subclavian/axillary vein thrombosis from thoracic outlet compression (cervical rib, scalenes) |
| Superficial thrombophlebitis | Linear tender erythematous cord along superficial vein; IV cannula site, varicose veins, thrombophilia; Trousseau's migratory = occult malignancy |
| AV fistula | Pulsatile/throbbing swelling, thrill, bruit; post-traumatic or iatrogenic |
| Venous injury / post-traumatic | History of trauma or surgery; venous hypertension in drained territory |
| Condition | Key Features |
|---|---|
| Cellulitis | Acute diffuse erythema with indistinct borders, warmth, tenderness; entry site (wound, eczema, tinea) in 77%; organisms: S. aureus, GAS; risk: lymphedema, venous insufficiency |
| Erysipelas | Superficial, sharply demarcated raised red plaque; high fever; GAS; spreads 2-10 cm/day |
| Necrotizing fasciitis (MUST NOT MISS) | Pain >> appearance; woody oedema; bullae, crepitus, skin necrosis; rapid sepsis; surgical emergency |
| Abscess | Fluctuant, tender, localised; MRSA in injection drug users |
| Septic arthritis | Acutely red, hot, tender joint; severely restricted ROM; fever; joint aspiration diagnostic |
| Osteomyelitis | Deep bone pain, local tenderness, fever; MRI is gold standard |
| Lymphangitis | Red streaking proximally from portal of entry; regional adenopathy |
| Condition | Key Features |
|---|---|
| Compartment syndrome (MUST NOT MISS) | 6 Ps: Pain (passive stretch - earliest), Pressure, Paraesthesia, Paralysis, Pallor, Pulselessness (late); post-fracture/crush; pressure >30 mmHg = fasciotomy |
| Fracture | Trauma history; point tenderness, deformity, crepitus, abnormal movement; pathological = through metastasis/cyst |
| Haematoma | Trauma/anticoagulation; tense, bruised, ecchymosis tracking distally |
| Muscle tear (biceps/triceps) | Acute exertion; "Popeye" sign (biceps); fusiform swelling, ecchymosis |
| Dislocation | Deformity + restricted ROM; neurovascular compromise |
| Ligament/tendon injury | Focal periarticular swelling, effusion, functional loss |
| Condition | Key Features |
|---|---|
| Secondary lymphedema - BCRL | Most common cause of chronic unilateral UL swelling; follows axillary node dissection + mastectomy + radiotherapy; non-pitting, starts at upper arm, spreads distally; recurrent cellulitis |
| Secondary lymphedema - other | Filariasis (Wuchereria bancrofti), other malignancy with axillary/mediastinal nodal involvement, post-radiotherapy, recurrent infections |
| Primary lymphedema | Very rare in upper limb; congenital or early-onset aplasia/hypoplasia of lymphatics |
| Stewart-Treves syndrome | Angiosarcoma (blue-red nodules) arising in chronic post-mastectomy lymphedema - rare but aggressive |
| Condition | Key Features |
|---|---|
| Lipoma | Soft, lobulated, compressible, non-tender, freely mobile; most common benign soft tissue tumour |
| Ganglion cyst | Tense, transilluminant; arises from joint capsule/tendon sheath; wrist most common |
| Soft tissue sarcoma | Deep, firm, >5 cm, painless, rapidly growing - urgent referral (2-week rule) |
| Haemangioma / Vascular malformation | Soft, compressible, bluish; enlarges on dependency |
| Axillary lymphadenopathy | Palpable nodal mass causing lymphatic/venous obstruction; breast cancer metastasis, lymphoma, melanoma |
| Bone tumour / metastasis | Pain at rest/night, bony swelling, pathological fracture |
| Condition | Key Features |
|---|---|
| CRPS (Complex Regional Pain Syndrome) | Post-injury or post-surgical; burning pain, allodynia, diffuse non-pitting oedema; skin colour/temperature changes (warm/red early → cold/dusky late); trophic changes; Sudeck's atrophy on X-ray |
| Condition | Key Features |
|---|---|
| IV extravasation | Localised swelling at cannula site; blistering/necrosis with vesicant chemotherapy agents |
| PICC/central line thrombosis | Catheter-associated UE-DVT (>90% of secondary UE-DVT) |
| Drug reaction / angioedema | ACE inhibitor-induced or hereditary; rapid-onset non-pitting, non-pruritic swelling; bradykinin-mediated |
| Calcium channel blocker oedema | Usually bilateral but can be asymmetric |
| Condition | Key Features |
|---|---|
| Gout | Acute monoarthritis; wrist, MCPs; exquisitely tender; negatively birefringent urate crystals |
| Pseudogout (CPPD) | Wrist, elbow; weakly positively birefringent calcium pyrophosphate crystals |
| Rheumatoid arthritis flare | Symmetric MCP/PIP joint swelling usually; can be asymmetric in early disease |
| Reactive arthritis | Follows infection; asymmetric oligoarthritis; urethritis + conjunctivitis (Reiter's triad) |
| Insect bite / envenomation | Rapid localised oedema; fang marks (snake bite); urticaria (allergic) |
| Priority | Diagnosis | Why Urgent |
|---|---|---|
| 🔴 Emergency | Compartment syndrome | Permanent ischaemic contracture within hours |
| 🔴 Emergency | Necrotizing fasciitis | Fatal if surgical debridement delayed |
| 🔴 Emergency | Septic arthritis | Joint destruction within 24-48 hours |
| 🟠 Urgent | UE-DVT | PE risk up to 33% |
| 🟠 Urgent | Acute limb ischaemia (arterial) | Limb loss within 6 hours |
| 🟡 Same-day | Cellulitis with systemic features | Bacteraemia, sepsis |
| 🟡 Same-day | Fracture with neurovascular compromise | Nerve/vessel injury |
| 🟢 Routine | Lymphedema, lipoma, ganglion, CRPS | Non-immediately life/limb threatening |
Unilateral Upper Limb Swelling
|
Trauma history?
YES → X-ray ± CT
NO ↓
Hot/red/fever?
YES → Cellulitis vs. NF vs. septic arthritis
(bloods, cultures, LRINEC score, USS/MRI)
NO ↓
Risk factors for DVT / catheter in situ?
YES → Duplex USS → Venography/MRV if inconclusive
NO ↓
Chronic, non-pitting, post-mastectomy?
YES → Lymphedema (clinical diagnosis ± lymphoscintigraphy)
NO ↓
Palpable mass?
YES → USS ± MRI ± biopsy (sarcoma protocol if >5cm/deep)
NO ↓
Post-injury, burning pain, allodynia?
YES → CRPS (clinical diagnosis, 3-phase bone scan)
Treatment for pain abdomen in k:co of abdominal koch
"abdominal tuberculosis" AND "pain" AND management
| Category | Clinical Scenario | Urgency |
|---|---|---|
| Active disease pain | Dull, colicky, chronic - disease not yet controlled or early treatment | Routine |
| Subacute obstruction | Intermittent colicky pain, distension, on-treatment | Urgent |
| Acute obstruction | Severe colicky pain, distension, vomiting, absolute constipation | Emergency |
| Perforation / Peritonitis | Sudden severe pain, guarding, rigidity, board-like abdomen | Emergency |
| Abscess | Localised pain, fever, tender mass | Urgent |
| Ascites pain | Dull ache, distension, shifting dullness | Routine |
Perforation can occur even during anti-TB treatment - always exclude in a k/c of abdominal Koch's with acute pain. - Sleisenger & Fordtran's GI and Liver Disease
| Phase | Duration | Drugs | Short form |
|---|---|---|---|
| Intensive phase | 2 months | Isoniazid (H) + Rifampicin (R) + Pyrazinamide (Z) + Ethambutol (E) | 2HRZE |
| Continuation phase | 4-10 months | Isoniazid (H) + Rifampicin (R) | 4-10HR |
Total duration 6-12 months standard; up to 12-18 months preferred for abdominal TB in many guidelines. Patients should be under combined physician and surgeon care. - Bailey & Love, 28th Ed.
| Drug | Dose | Indication |
|---|---|---|
| Antispasmodics (Hyoscine butylbromide/Buscopan) | 10-20 mg TDS/QDS PO or 20 mg IM/IV | Colicky pain from intestinal spasm/strictures |
| Paracetamol | 500 mg - 1 g TDS-QDS | Mild-moderate pain; safe with ATT |
| NSAIDs (Ibuprofen, Diclofenac) | With caution | Moderate pain; avoid if GI ulceration, poor nutrition, renal impairment |
| Proton pump inhibitor (Pantoprazole/Omeprazole) | 40 mg OD | GI protection, especially if on NSAIDs or with dyspepsia from ATT |
| Opioids (Tramadol, Morphine) | As required | Severe pain; short-term; avoid in obstruction unless under surgical care |
Avoid NSAIDs in malnourished patients and those with peritoneal involvement due to risk of GI ulceration and masking of perforation.
| Procedure | Indication |
|---|---|
| Strictureplasty | Single short ileal stricture (bowel-conserving) |
| Limited ileocolic resection + anastomosis | Terminal ileal/ileocolic hyperplastic disease |
| Bowel resection | Multiple closely placed strictures |
| Right hemicolectomy | Extensive ileocolic disease |
"The surgical principles are very similar to Crohn's disease - resections should be kept as conservative as possible." - Bailey & Love, 28th Ed.
| Situation | Preferred Operation |
|---|---|
| Active infection, poor general condition, malnourished | Resection of diseased segment + proximal ileostomy + distal mucus fistula (avoids anastomosis - high leak risk) |
| Good general condition, minimal contamination | Resection + primary anastomosis (rare in emergency) |
Avoid primary anastomosis in the presence of active infection, severe malnutrition, and poor general condition - anastomotic leak rate is very high. - Bailey & Love, 28th Ed.
K/C Abdominal Koch's + Pain Abdomen
↓
Emergency signs? (Guarding, Rigidity,
Free gas, Obstruction, Haemodynamic instability)
↓ ↓
YES NO
↓ ↓
Resuscitate (IVF, Is patient on ATT?
NGT, catheter, ↓
antibiotics, analgesia) YES → Check:
↓ 1. ATT adequacy/adherence
CT abdomen 2. LFTs (hepatotoxicity)
↓ 3. Drug sensitivities (MDR)
Obstruction? Perforation? ↓
↓ ↓ Optimise ATT
Resection + Resection + + Symptomatic pain relief
Ileostomy ±Anastomosis (Antispasmodics,
(or or Ileostomy Paracetamol, PPI)
anastomosis + Nutrition support
if fit) + Steroids if peritoneal TB
↓
Subacute obstruction on ATT?
→ NBM + IV fluids + NGT
→ Re-image post-ATT
→ Elective surgery if persists
(Strictureplasty / Resection)
- ATT is the primary treatment - surgical intervention is reserved for complications
- Pain relief should not be withheld - analgesia + antispasmodics are appropriate
- Patients should be under combined physician-surgeon care throughout
- Vigorous supportive care (nutrition, hydration, anaemia) is mandatory in all cases
- Obstruction may respond to ATT alone - always give medical therapy first
- In the emergency setting, do the minimum life-saving procedure - avoid anastomosis in active disease
- After any surgery, complete the full ATT course before considering further elective procedures
Continous loose stools since 7 days with normal CBC management
"persistent diarrhea" AND management
| Feature | Concern |
|---|---|
| Sunken eyes, dry mucosa, skin turgor reduced | Moderate-severe dehydration |
| HR >100, BP drop, oliguria/anuria | Haemodynamic compromise |
| High fever (>39°C) | Invasive infection despite normal CBC |
| Bloody/mucoid stools | Invasive pathogen, IBD flare |
| Persistent vomiting preventing ORS | IV rehydration needed |
| Age extremes (infant/elderly) | Higher risk of rapid deterioration |
| Immunocompromised, pregnant | Higher risk |
| Investigation | Reason |
|---|---|
| Stool microscopy (wet mount) | Giardia cysts/trophozoites, Entamoeba, Cryptosporidium oocysts |
| Stool R/E (routine/examination) | Ova, cysts, parasites, RBCs, pus cells, fat globules |
| Stool culture and sensitivity | Persistent bacterial cause (Salmonella, Campylobacter) |
| Stool for C. difficile toxin | If recent antibiotics use |
| Giardia stool antigen / ELISA | More sensitive than microscopy (~90% sensitivity) |
| Serum electrolytes (Na, K, Cl, HCO3) | Electrolyte depletion from prolonged diarrhoea |
| Blood glucose, urea, creatinine | Dehydration assessment |
| Serum albumin | Nutritional status / protein-losing enteropathy |
| Stool for reducing substances | If lactose intolerance suspected (especially post-viral) |
| Thyroid function (TSH) | If chronic/secretory pattern - hyperthyroidism |
| Category | Diagnosis | Key Clues |
|---|---|---|
| Protozoal (most important) | Giardia lamblia | Foul-smelling, greasy, frothy stools; bloating; no blood; contaminated water history |
| Protozoal | Cryptosporidium | Watery diarrhoea; immunocompromised patients particularly at risk |
| Protozoal | Entamoeba histolytica | Dysentery + RLQ pain (but may be non-bloody early); travel history |
| Post-viral | Post-infectious/prolonged viral gastroenteritis | Nausea, preceded by vomiting; community exposure; Norovirus, Rotavirus |
| Post-infectious | Secondary lactose intolerance | Bloating, gas, watery loose stools after viral GE; worse with dairy |
| Bacterial (non-invasive) | ETEC, Clostridium perfringens | Watery, no blood, no fever; food history |
| Drug-induced | Antibiotic-associated diarrhoea / C. difficile | Recent antibiotics in last 8 weeks |
| Osmotic | Dietary (sorbitol, fructose, artificial sweeteners) | Worse with specific foods; improves with fasting |
| Functional | Post-infectious IBS | Altered motility after GI infection; normal all investigations |
| Inflammatory (less likely with normal CBC) | IBD (Crohn's/UC early) | Recurrent episodes, blood/mucus, weight loss - normal CBC does not exclude |
| Preparation | Details |
|---|---|
| ORS sachets (WHO/UNICEF standard) | Dissolve 1 sachet in 1 litre of clean water |
| Home ORS | ½ tsp salt + 6 level tsp sugar in 1 litre clean water |
| Commercial ORS | Electral, Pedialyte, Enerzal etc. |
| Recommended | Avoid |
|---|---|
| Bananas, rice, applesauce, toast (BRAT diet) | Dairy products (if secondary lactose intolerance) |
| Boiled potatoes, dal, khichdi | Fatty/fried foods |
| Oral fluids (coconut water, ORS, clear soups) | Raw vegetables, spicy food |
| Soft, easily digestible foods | Alcohol, caffeine |
| Continue breastfeeding in infants | Fruit juices with high osmolality |
| Drug | Dose | Notes |
|---|---|---|
| Loperamide (Imodium) | 4 mg initially, then 2 mg after each loose stool; max 16 mg/day | Reduces motility; do NOT use with fever, bloody stools (risk of toxic megacolon, HUS) |
| Bismuth subsalicylate | 524 mg every 30-60 min, max 8 doses/day | Antimicrobial + anti-secretory; safe in most |
| Racecadotril (Acetorphan) | 1.5 mg/kg TDS (children); 100 mg TDS (adults) | Enkephalinase inhibitor; reduces secretion; safer than loperamide (no motility effect) |
| Smectite (Diosmectite) | 3 g TDS in water | Binds toxins/pathogens; safe in all ages; no systemic absorption |
| Drug | Dose | Duration |
|---|---|---|
| Tinidazole (first line - single dose preferred) | 2 g PO single dose | 1 day |
| Metronidazole | 400-500 mg TDS PO | 5-7 days |
| Nitazoxanide | 500 mg BD PO | 3 days |
"Treatment is not always successful regardless of drug used, and repeat courses may be necessary." - Tintinalli's Emergency Medicine
| Drug | Dose | Duration |
|---|---|---|
| Metronidazole (tissue amoebicide) | 400-800 mg TDS PO | 5-10 days |
| Diloxanide furoate (luminal amoebicide - eradicate cysts) | 500 mg TDS PO | 10 days |
| Give both drugs sequentially for complete cure |
| Drug | Dose | Duration | Used For |
|---|---|---|---|
| Azithromycin | 500 mg OD PO | 3 days (1 g single dose for traveller's diarrhoea) | Campylobacter, Shigella, ETEC, traveller's diarrhoea (first-line) |
| Ciprofloxacin | 500 mg BD PO | 3-5 days | Shigella, ETEC, Salmonella (severe), Vibrio |
| Rifaximin | 200 mg TDS PO | 3 days | Non-invasive traveller's diarrhoea; gut-limited, minimal systemic absorption |
| Metronidazole | 400 mg TDS PO | 5-7 days | Giardia, Amoeba, C. difficile |
Avoid antibiotics if STEC (E. coli O157:H7) suspected (bloody diarrhoea + low-grade fever + recent undercooked beef exposure) - antibiotics increase risk of haemolytic uraemic syndrome (HUS) - Goldman-Cecil Medicine; Washington Manual
7 days loose stools + Normal CBC
↓
Assess dehydration
↓
Mild-Moderate Severe
ORS + Diet IV NS/RL + ORS
Zinc supplementation Electrolyte correction
↓
Send: Stool R/E + C&S, Giardia Ag, Serum electrolytes
↓
Symptomatic (no fever, no blood):
Loperamide OR Racecadotril + Smectite
↓
Empirical specific treatment:
Likely Giardia → Tinidazole 2g single dose
Likely Amoeba → Metronidazole + Diloxanide
Systemic features → Azithromycin or Ciprofloxacin
↓
Review stool results → Targeted therapy
↓
Not improving at 2 weeks?
→ Refer gastroenterology
→ Consider colonoscopy (IBD, microscopic colitis)
→ Lactose breath test, thyroid function